Company profile
Speakeasy Cannabis Club Ltd.
OTC: SPBBF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Rock Creek, BCReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 23
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ market scale, Piotroski F
Methodology →Revenue TTM
$759.9k
Rev growth YoY (TTM)
+16129.5%
Net income (FY)
-$2.0M
Employees
—
as of 2026-07-12
Market cap
$1.3k
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02020
Net income-$2.0M-$2.0M2020
Operating income-$4.1M-$4.1M2020
Total assets$17.8M$17.8M2020
Liabilities$4.7M$4.7M2020
Equity$13.0M$13.0M2020
Revenue trend
FY2016 – FY2020 · USD
FY16
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Speakeasy Cannabis Club Ltd.’s revenue?
Speakeasy Cannabis Club Ltd. booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Pure Global Cannabis Inc.——Aamaxan Transport Group, Inc.——Xcorporeal, Inc.——Biomagnetics Diagnostics Corp.——PhaseRx, Inc.——Imagin Medical Inc.——Key facts
CEOPatrick Geen
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersRock Creek, BC
ExchangeOTC: SPBBF
Employees—
IPO date2018-05-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.